There are two FDA-approved medications for the metabolic disorder known as MASH. Roche is paying $2.4 billion to acquire 89bio and its late-stage MASH drug, giving the Swiss pharmaceutical giant the ...
Immunometabolism has profoundly elucidated the central role of metabolism in regulating immune responses. Metabolism not only serves as the foundation for ...
Cardiometabolic research has increasingly recognized the centrality of metabolic dysregulation and dietary imbalances in the development and progression of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results